We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants
SGYPW

Delisted

SGYPW was delisted on the 6th of December, 2016.

Back to rankings

4 hedge funds and large institutions have $1.01M invested in Synergy Pharmaceuticals, Inc. - Warrants in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

40% more capital invested

Capital invested by funds: $725K → $1.01M (+$288K)

33% more funds holding

Funds holding: 3 → 4 (+1)

14% more call options, than puts

Call options by funds: $24K | Put options by funds: $21K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
$24K
Puts
$21K
Net Calls
+$3K
Net Calls Change
+$53K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$637K
2
U
UBS
Switzerland
+$2.14K

Top Sellers

Rank Fund Capital Flow
1
CAL
Capital Advisors Ltd
Ohio
-$10K
2
TRCT
Tower Research Capital (TRC)
New York
-$540
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$515K +$637K +389,982 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$495K – – –
U
3
UBS
Switzerland
$2K +$2.14K +1,309 New
TRCT
4
Tower Research Capital (TRC)
New York
$1K -$540 -331 -32%
CAL
5
Capital Advisors Ltd
Ohio
– -$10K -1,799 Closed

SGYPW Hedge Fund Activity: Q2 2014 in Review

4 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q2 2014, worth a combined $1.01M — up 40% from $725K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SGYPW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $637K. The largest seller was Capital Advisors Ltd, exiting entirely with an estimated $10K sold.

  • 4 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q2 2014, up from 3 in Q1 2014.
  • Funds reported $1.01M of Synergy Pharmaceuticals, Inc. - Warrants stock for Q2 2014, up 40% quarter-over-quarter.
  • 2 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q2 2014 and 1 closed out, a net change of +1 holder.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q2 2014 was Sabby Management, an estimated $637K added.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q2 2014 was Capital Advisors Ltd, an estimated $10K sold.

Based on aggregated 13F filings for Q2 2014.